The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
How Membrane-Active Peptides Get into Lipid Membranes
Abstract
The structure-function relationship for a family of antimicrobial peptides (AMPs) from the skin of Australian tree frogs is discussed and compared with that of peptide toxins from bee and Australian scorpion venoms. Although these membrane-active peptides induce a similar cellular fate by disrupting the lipid bilayer integrity, their lytic activity is achieved via different modes of action, which are investigated in relation to amino acid sequence, secondary structure, and membrane lipid composition. In order to better understand what structural features govern the interaction between peptides and lipid membranes, cell-penetrating peptides (CPPs), which translocate through the membrane without compromising its integrity, are also discussed. AMPs possess membrane lytic activities that are naturally designed to target the cellular membrane of pathogens or competitors. They are extremely diverse in amino acid composition and often show specificity against a particular strain of microbe. Since our antibiotic arsenal is declining precariously in the face of the rise in multiantibiotic resistance, AMPs increasingly are seen as a promising alternative. In an effort to understand their molecular mechanism, biophysical studies of a myriad of AMPs have been reported, yet no unifying mechanism has emerged, rendering difficult the rational design of drug leads. Similarly, a wide variety of cytotoxic peptides are found in venoms, the best known being melittin, yet again, predicting their activity based on a particular amino acid composition or secondary structure remains elusive. A common feature of these membrane-active peptides is their preference for the lipid environment. Indeed, they are mainly unstructured in solution and, in the presence of lipid membranes, quickly adsorb onto the surface, change their secondary structure, eventually insert into the hydrophobic core of the membrane bilayer, and finally disrupt the bilayer integrity. These steps define the molecular mechanism by which these membrane-active peptides lyse membranes. The last class of membrane-active peptides discussed are the CPPs, which translocate across the lipid bilayer without inducing severe disruption and have potential as drug vehicles. CPPs are typically highly charged and can show antimicrobial activity by targeting an intracellular target rather than via a direct membrane lytic mechanism. A critical aspect in the structure-function relationship of membrane-active peptides is their specific activity relative to the lipid membrane composition of the cell target. Cell membranes have a wide diversity of lipids, and those of eukaryotic and prokaryotic species differ greatly in composition and structure. The activity of AMPs from Australian tree frogs, toxins, and CPPs has been investigated within various lipid systems to assess whether a relationship between peptide and membrane composition could be identified. NMR spectroscopy techniques are being used to gain atomistic details of how these membrane-active peptides interact with model membranes and cells, and in particular, competitive assays demonstrate the difference between affinity and activity for a specific lipid environment. Overall, the interactions between these relatively small sized peptides and various lipid bilayers give insight into how these peptides function at the membrane interface.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Prediction of protein antigenic determinants from amino acid sequences.
Hopp, T. P., & Woods, K. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3824 · Cited by 3,705
Shai, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00200-x · Cited by 1,869
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Bacterial membrane lipids: diversity in structures and pathways
Sohlenkamp, C., & Geiger, O. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv008 · Cited by 1,185
Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., & Huang, H. W. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75802-x · Cited by 1,114
Horvath, S. E., & Daum, G. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.07.002 · Cited by 907
Park, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Lipid domains in bacterial membranes and the action of antimicrobial agents
Epand, R. M., & Epand, R. F. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.023 · Cited by 624
Antibiotics as signalling molecules
Yim, G., Huimi Wang, H., & Davies FRS, J. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2044 · Cited by 495
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Mishra, A., Lai, G. H., Schmidt, N. W., Sun, V. Z., Rodriguez, A. R., Tong, R., Tang, L., Cheng, J., Deming, T. J., Kamei, D. T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108795108 · Cited by 330
Rozek, T., Wegener, K. L., Bowie, J. H., Olver, I. N., Carver, J. A., Wallace, J. C., & Tyler, M. J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01536.x · Cited by 288
The Structural Role of Cholesterol in Cell Membranes: From Condensed Bilayers to Lipid Rafts
Krause, M. R., & Regen, S. L. (2014) · Accounts of Chemical Research · doi:10.1021/ar500260t · Cited by 269
Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action
Scocchi, M., Tossi, A., & Gennaro, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0721-7 · Cited by 267
Apponyi, M. A., Pukala, T. L., Brinkworth, C. S., Maselli, V. M., Bowie, J. H., Tyler, M. J., Booker, G. W., Wallace, J. C., Carver, J. A., Separovic, F., et al. (2004) · Peptides · doi:10.1016/j.peptides.2004.03.006 · Cited by 242
Self-citationThe antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism
Fernandez, D. I., Le Brun, A. P., Whitwell, T. C., Sani, M.-A., James, M., & Separovic, F. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp43099a · Cited by 200
Self-citationDeshayes, S., Heitz, A., Morris, M. C., Charnet, P., Divita, G., & Heitz, F. (2004) · Biochemistry · doi:10.1021/bi035682s · Cited by 198
Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria
Li, W., Tailhades, J., O’Brien-Simpson, N. M., Separovic, F., Otvos, L., Hossain, M. A., & Wade, J. D. (2014) · Amino Acids · doi:10.1007/s00726-014-1820-1 · Cited by 192
Self-citationMechanism of the Cell-Penetrating Peptide Transportan 10 Permeation of Lipid Bilayers
Yandek, L. E., Pokorny, A., Florén, A., Knoelke, K., Langel, Ü., & Almeida, P. F. F. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.100198 · Cited by 190
Yoneyama, F., Imura, Y., Ohno, K., Zendo, T., Nakayama, J., Matsuzaki, K., & Sonomoto, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00209-09 · Cited by 154
Wong, H. N. C., Bowie, J. H., & Carver, J. A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00545.x · Cited by 142
Dong, N., Ma, Q., Shan, A., Lv, Y., Hu, W., Gu, Y., & Li, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06327-11 · Cited by 141
Purification and Properties of Proline-Rich Antimicrobial Peptides from Sheep and Goat Leukocytes
Валерьевна, Ш. О., Brogden, K. A., Zhao, C., Nguyen, T. X., Kokryakov, V. N., & Lehrer, R. I. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.4106-4111.1999 · Cited by 118
Synergistic Transmembrane Alignment of the Antimicrobial Heterodimer PGLa/Magainin
Tremouilhac, P., Strandberg, E., Wadhwani, P., & Ulrich, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604759200 · Cited by 107
Salnikov, E. S., & Bechinger, B. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.01.070 · Cited by 106
Park, S., Kim, J., Shin, S.-O., Jeong, C.-Y., Kim, M., Shin, S. Y., Cheong, G., Park, Y., & Hahm, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.090 · Cited by 92
Length-Dependent Formation of Transmembrane Pores by 310-Helical α-Aminoisobutyric Acid Foldamers
Jones, J. E., Diemer, V., Adam, C., Raftery, J., Ruscoe, R. E., Sengel, J. T., Wallace, M. I., Bader, A., Cockroft, S. L., Clayden, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b12057 · Cited by 89
The Prototypic Cyclotide Kalata B1 Has a Unique Mechanism of Entering Cells
Henriques, S. T., Huang, Y., Chaousis, S., Sani, M., Poth, A. G., Separovic, F., & Craik, D. J. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.07.012 · Cited by 88
Self-citationPokorny, A., & Almeida, P. F. F. (2005) · Biochemistry · doi:10.1021/bi0506371 · Cited by 79
Melittin peptides exhibit different activity on different cells and model membranes
Jamasbi, E., Batinovic, S., Sharples, R. A., Sani, M., Robins-Browne, R. M., Wade, J. D., Separovic, F., & Hossain, M. A. (2014) · Amino Acids · doi:10.1007/s00726-014-1833-9 · Cited by 76
Self-citationLi, W., O’brien-simpson, N. M., Tailhades, J., Pantarat, N., Dawson, R. M., Otvos, L. J., Reynolds, E. C., Separovic, F., Hossain, M. A., & Wade, J. D. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.08.011 · Cited by 66
Self-citationAdaptation of the bacterial membrane to changing environments using aminoacylated phospholipids
Roy, H., Dare, K., & Ibba, M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06563.x · Cited by 66
Lipid Composition of Staphylococcus aureus and Its Derived L‐forms
Hayami, M., Okabe, A., Kariyama, R., Abe, M., & Kanemasa, Y. (1979) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1979.tb00483.x · Cited by 65
Sani, M., Henriques, S. T., Weber, D. K., & Separovic, F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.643262 · Cited by 64
Self-citationMembrane interactions and biological activity of antimicrobial peptides from Australian scorpion
Luna-Ramírez, K. S., Sani, M., Silva-Sánchez, J., Jiménez-Vargas, J. M., Reyna-Flores, F., Winkel, K. D., Wright, C. E., Possani, L. D., & Separovic, F. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.10.022 · Cited by 36
Self-citationNeubauer, C., Dalleska, N. F., Cowley, E. S., Shikuma, N. J., Wu, C. ‐., Sessions, A. L., & Newman, D. K. (2015) · Geobiology · doi:10.1111/gbi.12143 · Cited by 23
A Dimerization “Switch” in the Internalization Mechanism of a Cell-Penetrating Peptide
Moss, J. A., Lillo, A. M., Kim, Y. S., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0443171 · Cited by 9
Cited by
The value of antimicrobial peptides in the age of resistance
Magana, M., Pushpanathan, M., Santos, A. L., Leanse, L., Fernandez, M., Ioannidis, A., Giulianotti, M. A., Apidianakis, Y., Bradfute, S., Ferguson, A. L., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30327-3 · Cited by 1,150
Antimicrobial Peptides: Mechanisms of Action and Resistance
Bechinger, B., & Gorr, S.-U. (2017) · Journal of Dental Research · doi:10.1177/0022034516679973 · Cited by 739
Chemically modified and conjugated antimicrobial peptides against superbugs
Li, W., Separovic, F., O'Brien-Simpson, N. M., & Wade, J. D. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01026j · Cited by 439
Self-citationMode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms
Benfield, A. H., & Henriques, S. T. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.610997 · Cited by 367
Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity
Kalafatovic, D., & Giralt, E. (2017) · Molecules · doi:10.3390/molecules22111929 · Cited by 302
Metadata
- Authors
- Sani, M.-A., & Separovic, F.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-05-17
- Volume
- 49
- Issue
- 6
- Pages
- 1130-1138
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2403862021
- Cited by
- 472
- References
- 38
- FWCI
- 36.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.